J2185Meropenem

Published CMS Medicare Part B payment-limit context for J2185, with recent quarterly history and calculated package-level strength context from the CMS crosswalk.

CMS payment limit

$0.325

per 100 MG · Medicare Part B

Down 12.4%from $0.371 in 2026-Q2

Current quarter: 2026-Q3FinalEffective July 1, 2026
Billing unit: 100 MG

Payment limit over time

$0.4515$0.3095

2024-Q4: $0.354; 2025-Q1: $0.388; 2025-Q2: $0.431; 2025-Q3: $0.436; 2025-Q4: $0.421; 2026-Q1: $0.383; 2026-Q2: $0.371; 2026-Q3: $0.325

No current FDA shortage matchThe latest completed FDA data has no affected record matching the Meropenem ingredient family (FDA data as of August 20, 2026).

Email me when FDA shortage status changes

Meropenem

Package figures are calculated from the CMS per-unit payment limit × billable units per package; they are not CMS-published package-level payment limits.

Other Meropenem presentations

2 other CMS codes

Source-linked same ingredient-family context, not recommendations, substitutes, or clinical or billing equivalence.

Swipe to see all columns

HCPCS	CMS description	Current quarter 2026-Q3	Prior quarter 2026-Q2	Change	NDCs	View history
J2183	Inj meropenem (wg crit care)	$1.408 per 100 MG	$1.476 per 100 MG	Down 4.6%
J2184	Inj, meropenem (b. braun)	$1.867 per 100 MG	$1.974 per 100 MG	Down 5.4%

Put another code on your radar.

Browse the CMS directory for published payment-limit context across drugs, NDCs, and source-backed HCPCS Level II drug codes.

Explore CMS codes